BKFCF yields 5.65% · PFE yields 6.13%● Live data
📍 BKFCF pulled ahead of the other in Year 1
Combined, BKFCF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BKFCF + PFE for your $10,000?
Bank of Communications Co., Ltd. provides commercial banking products and services. The company operates through four business segments: Corporate Banking, Personal Banking, Treasury Businesses, and Other Businesses. It offers personal banking products and services, including savings deposit products, personal certificate of deposits, foreign currency deposit, and salary financing A products; mortgage and unsecured loans; bank cards; airport and personal wealth management advisor services; and physical precious metals, and structured deposits and wealth management products, as well as precious metal and commodity trading services. The company also provides corporate banking products and services comprising structured deposits and corporate certificate of deposits; syndicated loans and corporation overdraft services; wealth management services; investment banking and offshore banking services; corporate cash management and industrial chain financing services; structured deposits and wealth management products; and precious metal leasing, and precious metal and commodity trading services. In addition, it offers international banking services, such as corporate forex wealth management, document settlement, remittance and bill, and trade finance services; and interbank financing services. Further, the company provides financial leasing, trust investment, fund management, life insurance, securities dealing and brokerage, general insurance and reinsurance, debt-to-equity swaps, and financial products issuing and financial consulting services. As of December 31, 2021, It operated 248 branches in Mainland China; and 23 overseas branches and representative offices in 18 countries and regions with 69 overseas operating outlets. The company was founded in 1908 and is headquartered in Shanghai, the People's Republic of China.
Full BKFCF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.